MAKO Surgical

  • Why Investors are Bullish on Mazor Robotics

    By George Budwell - August 26, 2013 | Tickers: ISRG, MAKO

    One of the best strategies to earn market-beating returns is to invest in companies possessing ground-breaking technologies that have yet to be discovered by the broader market. The medical robotic company Mazor Robotics (NASDAQ: MZOR) is the maker of the state-of-the-art spinal surgery system Renaissance™, which enables surgeons to conduct spine surgeries in an accurate and secure manner. Although the system has been commercially available since 2010, physicians are only more »

  • Is a Huge Share Buyback The Cure For This Healthcare Stock?

    By Bob Ciura - July 31, 2013 | Tickers: ISRG, JNJ, MAKO

    Beleaguered healthcare stock Intuitive Surgical (NASDAQ: ISRG) recently announced a new, massive share repurchase authorization. The buyback couldn’t come at a better time. The stock is reeling after a hugely disappointing quarterly report and widespread fears about the safety of its revolutionary da Vinci surgical robots.

    Should investors take this news seriously? Or is management simply trying to buy itself time until it can sort out its underlying problems more »

  • Intuitive Surgical: Is Growth Over?

    By Jason Bond - July 31, 2013 | Tickers: ISRG, IRBT, MAKO

    Intuitive Surgical (NASDAQ: ISRG), the industry leader in robotic assisted surgery, has come a long way from its founding in 1995 and IPO in 2000. It has gone from a $9 IPO in 2000 all the way to $500 per share earlier this year. Now that the stock has fallen back below $400, is the stock a buy, hold, or sell?

    The product

    There is no doubt that Intuitive Surgical more »

  • This Health Care Stock Is Rapidly Approaching Buy Territory

    By Bob Ciura - July 22, 2013 | Tickers: ISRG, JNJ, MAKO

    Health-care stock Intuitive Surgical (NASDAQ: ISRG) used to be a favorite among growth investors just a few quarters ago. The company grew sales and profits at double-digit rates like clockwork and had a soaring share price reflecting its outstanding results.

    All that has changed, and the good times seem like an eternity ago. The company’s newly released quarterly results confirmed what investors had feared about the state of its more »

  • Is Now the Time to Buy Medical Device Makers?

    By Jason Hall - July 18, 2013 | Tickers: BSX, MAKO, MDT, STJ, SYK

    As of this writing, the S&P 500 is up over 17% this year, while many of the biggest names in medical devices have run even farther. If we go back to last June 28 -- when the US Supreme Court ruled in favor of Obamacare and its 2.3% excise tax on medical device makers' gross revenues, medical device stocks have run even higher. Motley Fool Contributor Dan Caplinger described more »

  • The Market For This Company is Set to Explode

    By Mohammed Shaaban - July 16, 2013 | Tickers: JNJ, MAKO, SYK, ZMH

    After World War Two, The United States of America witnessed the largest population increase in its history. Birth rates reached 25 per 1000 people, while death rates hovered at 9.5 per 1000, resulting in what came to be known as the baby boomer generation. Born between 1946 and 1964, the age range of this generation is currently between 49 years and 67. 

    76 million strong, second only to millennials more »

  • Can This Robot Doctor Heal Itself?

    By Leo Sun - July 12, 2013 | Tickers: ARAY, ISRG, MAKO | Editor's Choice

    Shares of surgical robot maker Intuitive Surgical (NASDAQ: ISRG) plunged 16% on July 9, after the Sunnyvale, Calif.-based company warned that its second quarter revenue would come in below analyst estimates when it reports earnings on July 18.

    It’s been a chaotic year for Intuitive Surgical, which produces the da Vinci surgical robot that was once the darling of Wall Street. Despite rising 2,700% over the past more »

  • What Is Missed on Intuitive Surgical's Big Miss

    By Dana Blankenhorn - July 11, 2013 | Tickers: ARAY, ISRG, MAKO | Editor's Choice

    Investors got little warning on Intuitive Surgical's (NASDAQ: ISRG) big second quarter miss. The first most heard about it might have been the company's own press release – the company doesn't officially report until next week.

    In practical terms the miss isn't much – revenue of $575 million against an expected $630 million, and net income of $160 million instead of $177.7 million. But the stock, which more »

  • This Health Care Stock Isn't Out of the Woods

    By Bob Ciura - July 10, 2013 | Tickers: ISRG, JNJ, MAKO

    Over the past year, Intuitive Surgical (NASDAQ: ISRG) has been mired in a mix of controversy pertaining to the safety of its revolutionary da Vinci surgical robots. Reports first leaked throughout the media questioning the safety of the company’s surgical systems. In fact, CNBC did a detailed report that brought the issue to the forefront of the financial media.

    At the time, those fears were not yet substantiated. It more »

  • Terminal or Turnaround?

    By Ian Richards - July 4, 2013 | Tickers: CRW, CUP, MAKO, WPRT, WETF

    Until the beginning of 2012, my own business had first call on both my time and available capital. I recently sold that business and I am building a portfolio to eventually see me through retirement.

    So far, I am generally doing well. But I have to admit that amongst the winners I have also managed to pick a few stinkers. Deciding what to do with these is a common problem more »

  • Jump In Early for the Biggest Multi-Baggers

    By Ian Richards - July 2, 2013 | Tickers: MAKO, MZOR, PSIX, WPRT

    Wouldn’t it be great to have bought Berkshire Hathaway, Microsoft or Dell at an early stage and bagged huge returns? Of course, there’s no such thing as a free lunch and if you base your entire investment strategy on investing in small, risky companies then the result is not likely to be a happy one.

    But, just for fun, it doesn’t hurt to put a small amount more »

  • A Regular Fool's Retirement Portfolio: Razors, Bubbles and Robot Doctors

    By Jason Hall - June 26, 2013 | Tickers: ISRG, MAKO, SODA

    I've identified a handful of companies that use the so-called "razor and blades" model to deliver predictable, long-term results. Some are just starting, some have a sustained record of success. But all of them are part of my retirement portfolio, which means I'm hoping to hold them forever. Go here to see how I'm doing. Will you learn more from my successes or my inevitable mistakes? 

    Razors more »

  • Capitalizing on the Medical Trends of Tomorrow

    By Ryan Guenette - June 10, 2013 | Tickers: BSX, ISRG, MAKO, SYK, TFX

    A leader in the medical device industry, Intuitive Surgical Incorporated(NASDAQ: ISRG) has been trounced year to date by the Dow Jones Industrial Average, rising only 2.00% compared to the 16.41% return offered by the blue chip average.   

    Intuitive Surgical designs, manufacturers, and markets da Vinci Surgical Systems and related instruments and accessories. Based on market capitalization, the company is valued at $20.09 billion. Fundamentally, the more »

  • This High-Growth Health Care Stock's Troubles Continue

    By Bob Ciura - May 13, 2013 | Tickers: ISRG, JNJ, MAKO

    While the Dow Jones Industrial Average crosses 15,000 and the S&P 500 Index breaks historical records of its own, a high-growth health care stock languishes. Intuitive Surgical (NASDAQ: ISRG), known for delivering its investors spectacular revenue and earnings growth quarter-after-quarter, continues to struggle with swirling rumors and accusations regarding the safety of its revolutionary da Vinci surgical robots.

    Recently, CNBC reported that Intuitive Surgical warned hospitals that a more »

  • Coast is clear for Intuitive Surgical?

    By James Wayman - April 25, 2013 | Tickers: ISRG, MAKO

    I’m a skeptic. Let’s put that out there. Being a skeptic does two things: elicits rational caution and causes me to be late to the party sometimes. Transplants, drug-eluting heart stents, exotic proteins from venomous creatures – all pretty useful. But the robotic surgery thing seems a bit like a fad. Remember “laser surgery”? Lasers: great for eyes, not so necessary for belly surgery. A physician once likened the more »

  • MAKO Surgical Battles Back into the Ring

    By Erik Eason - March 29, 2013 | Tickers: ISRG, MAKO, SNN, SYK, ZMH

    MAKO Surgical’s (NASDAQ: MAKO) fourth-quarter results answered the mail on all three of the Market’s concerns: Strong sales of RIO surgical robots; Record number of surgical procedures; Pricing holds firm while the expense ratio continues to decline. It is a prize fighter back in the ring, yet the Market yawned. So what is it this time?

    In a nutshell: “Show me.” The market wants to see a sustained more »

  • A New Survery Will Boost These Medical Device Companies

    By Callum Turcan - March 27, 2013 | Tickers: HCA, ISRG, MAKO

    On Wednesday the Journal of the American Medical Association released survey data that stated that since 2009 the US could have saved $14 billion in health-plan costs and 50,000 years of sick time if only minimally invasive surgeries had been used. They tracked 6 different procedures since 2009 to see what kind of impact minimally invasive surgeries will have on the healthcare industry. Minimally invasive surgeries can cut costs more »

  • The Jedi Portfolio

    By Jon Quast - March 25, 2013 | Tickers: HPQ, IMAX, ISRG, MAKO, DIS

    Although I am unaware of the Galactic Republic having a Kenobi Skywalker Industrial Average, wouldn't it be cool if you could invest like a Jedi?  Well, here's a couple of Jedi-like investments that would make even master Yoda proud.

    Holographic Images

    One of the most memorable scenes from the original trilogy was the holographic image of Princess Leia pleading "help me Obi Wan Kenobi."  The technology to produce more »

  • A Second Chance to Buy Intuitive Surgical

    By Siddharth Dalal - March 18, 2013 | Tickers: HNSN, ISRG, MAKO


    On Feb. 28, a few minutes before closing, a single research paper sent Intuitive Surgical (NASDAQ: ISRG) tanking from the $570ish range to under $500. The widely circulated paper concluded that overall outcomes in hysterectomies using Intuitive's Da Vinci robot were no better than laparoscopic surgery -- and that the robot option was more expensive. Read the paper here. Critics of the paper say its authors did not consider faster more »

  • An Attractive Time to Invest in Robotic Surgery

    By Greg Williamson - March 18, 2013 | Tickers: ISRG, MAKO

    Intuitive Surgical (NASDAQ: ISRG) is widely known for its successful da Vinci robotic surgical system, which is used for a wide variety of minimally invasive surgeries. The da Vinci system consists of robotic arms equipped with surgical equipment and a high-tech camera system, which provides a 3D image to a nearby console operated by the physician. Some of the documented and proven benefits over conventional surgery are a reduced size more »

  • Page 1 of 4